Columnist Dagmar Munn says she has often felt out of place in the ALS community because of the slower pace of her disease ...

A Regina mother who was one of the first ALS patients to test a new treatment is now celebrating its accelerated approval in Canada for adults with an ultra-rare form of the disease.

Pathmaker's MyoRegulator is designed to ease hyperexcitability and delivers an electrical current to the spinal cord and ...

Damaged muscles in ALS patients release proteins previously linked only to brain disease In a nutshell Researchers discovered ...

Tris Pharma announced positive topline results from the ALLEVIATE-2 phase III clinical trial of investigational cebranopadol to treat moderate-to-severe acute pain after bunionectomy surgery. Axonal ...

Scientists used positron emission tomography (PET) with edaravone, a drug used to treat ALS, to detect oxidative stress, which leads to brain damage, offering a clear path to detecting neurological ...

Scientists at St. Jude Children’s Research Hospital have used positron emission tomography (PET) with edaravone, a drug used ...

With the involvement of around 30 specialist practices across Germany, DZNE will investigate whether dedicated memory tests on smartphones can help to detect mild cognitive impairment (MCI) at an ...

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of eleven abstracts covering research in amyotrophic lateral sclerosis (ALS) at the 2025 Muscular Dystrophy Association ...

PET imaging is improved by employing edaravone to track oxidative stress, allowing for earlier detection of neurodegenerative ...

Experts warn that difficulty swallowing, producing excess saliva or even drooling could be a sign of motor neurone disease ...

According to the NHS, MS is a disease which affects both the brain and spinal cord, and causes a wide range of potential ...